Skip to main content
Aether Industries Limited logo

Aether Industries Limited — Investor Relations & Filings

Ticker · AETHER ISIN · INE0BWX01014 LEI · 335800N7FL6LX9XELD45 BSE.NS Manufacturing
Open in API
Filings indexed 537 across all filing types
Latest filing 2022-11-03 Board/Management Inform…
Country IN India
Listing BSE.NS AETHER

About Aether Industries Limited

https://aether.co.in/

Aether Industries Limited focuses on the production of advanced intermediates involving complex and differentiated chemistry. The organization operates through three distinct business models: large-scale manufacturing of proprietary products, contract research and manufacturing services (CRAMS), and contract manufacturing. Its portfolio supports applications in pharmaceuticals, agrochemicals, material science, and high-performance polymers. Aether leverages integrated research and development capabilities, utilizing dedicated R&D centers and pilot plants to scale chemical processes from initial development to commercial volumes. Technical expertise includes specialized chemistries such as Grignard reactions, hydrogenation, and ethylene oxide chemistry. The company provides high-value building blocks and customized manufacturing solutions, emphasizing innovation and process efficiency to meet the requirements of a global client base.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial results/Other business matters
Board/Management Information Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled for November 11, 2022. The purpose of the meeting is to consider unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2022. The document references Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to board meeting disclosures. The document is brief (1724 characters) and serves as an announcement of a board meeting rather than the financial results themselves or a detailed report. Therefore, it is best classified as a Board/Management Information filing (MANG), which covers announcements of board meetings and related management information.
2022-11-03 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a press release about the renewal of a long-term agreement for two products. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The document includes a press release published in newspapers and requests the exchanges to take the information on record. There is no financial data, no detailed report, no management discussion, or earnings information. The document is essentially an announcement of a press release and not a full report or financial filing. It is also not a certification or insider dealing report. Given the nature and length (under 10,000 characters) and the content, this fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about a material event disclosure under SEBI regulations, not a full report or financial statement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-10-31 English
Awarding orders/contract
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges regarding the renewal of a long-term agreement for product supply. It references compliance with SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The document does not contain financial statements, detailed financial data, or management discussion. It is an announcement of a corporate event (contract renewal) rather than a report or detailed filing. The length is only 1882 characters, indicating it is a brief announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-10-29 English
Reply to Clarification Sought
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India Limited regarding a pre-intimation for the inauguration of a newly expanded R&D laboratory. It references compliance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content focuses on providing clarifications about the expansion, capacity, investment, financing, and rationale behind the R&D lab expansion. There are no financial statements, earnings data, or detailed financial analysis present. The document is an announcement of a corporate event related to operational expansion rather than a financial report or regulatory filing of financial results. It is also not a report publication announcement or certification. Given the nature of the content as an update on a material event disclosed to the stock exchange, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-10-28 English
General updates
Regulatory Filings Classification · 95% confidence The document is an intimation letter addressed to stock exchanges regarding the inauguration of a newly expanded R&D laboratory. It includes details about capacity, investment amount, mode of financing, and rationale for the expansion. There are no financial statements, earnings data, or regulatory filings such as annual or quarterly reports. The document is a corporate announcement about a business development event, specifically the inauguration of a facility, which is a typical regulatory disclosure under SEBI Listing Obligations. It does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a management or board change announcement, nor a voting result or capital change. The document is a regulatory announcement informing the market about a material event related to the company’s operations. Therefore, the best fitting category is Regulatory Filings (RNS). The document length is over 6000 characters, so it is not a brief report publication announcement. Confidence is high due to clear content and context.
2022-10-12 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the inauguration of a newly expanded R&D laboratory by Aether Industries Limited. It is addressed to stock exchanges under SEBI regulations and provides detailed information about the new R&D center, its capabilities, investment, and expected impact on the business. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is an announcement of a corporate event rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a regulatory filing or certification. The best fitting category is a Regulatory Filing (RNS) as it is a general regulatory announcement under SEBI regulations about a corporate development event.
2022-10-12 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.